New mechanistic insights of the pathogenicity of high-risk cytomegalovirus (CMV) strains derived from breast cancer: Hope for new cancer therapy options
- PMID: 35709661
- PMCID: PMC9201002
- DOI: 10.1016/j.ebiom.2022.104103
New mechanistic insights of the pathogenicity of high-risk cytomegalovirus (CMV) strains derived from breast cancer: Hope for new cancer therapy options
Conflict of interest statement
Declaration of interests The author holds a patent to identify and treat a CMV strain associated with cancer.